skip to primary navigationskip to content

Taking parked therapies into overdrive

last modified Apr 28, 2014 04:09 PM
Healx3 is aiming to breathe new life into parked therapeutics and dormant IP in the biopharmaceutical industry.


The start-up, based at ideaSpace West, hopes to take the medical technology parked by biopharmaceutical companies and turn it into new drugs and therapies. Healx3 is currently in talks with biopharma companies on potential partnerships.

In an interview with Business Weekly, CEO Tim Guilliams, who holds a PhD in molecular neuroscience from the University of Cambridge, says: “Around 90 per cent of drug development projects never make it to market – leaving a vast amount of parked bio-assets on company benches.

“Some of these assets still have therapeutic potential, but do not cure patients or generate revenue. Healx3 is specialising in the upcycle and out-licensing of parked therapeutics and dormant IP in the biopharmaceutical industry.

“By enabling companies to generate new revenue streams and promote collaborative innovation within the industry, our activities will help deliver the next generation of therapeutics to patients in need.”

Healx3 is currently self-funded but aims to seek angel support once it has created strategic partnerships, launching a pilot with around 10 assets and pushing for seed capital around September.

To read the full article visit here

For more on Healx3 see

RSS Feed Latest news

ideaSpace 'Dream Team' Fronteer, featured in E-Learn Magazine

Oct 24, 2016

E-Learning magazine champions Fronteer's new product 'Ally', which makes course content more accessible for students and instructors.

Two ideaSpace Companies Scoop Prizes at the 7th Annual Discovering Start-Ups Competition!

Oct 21, 2016

Congratulations to ideaSpace members 8Power and Focal Point Positioning who have been announced as winners of the 2016 Cambridge Wireless Discovering Start-Ups competition, along with risk analytics company, AlgoDynamix.

Polysolar celebrate Top Innovation Award

Oct 10, 2016

Polysolar who develop, design, and project-manage Building Integrated Photovoltaic (BIPV) solutions have won Cambridge News Top Innovation 2016 Award

Healx secures £1.5m from Amadeus Capital and investors to combat rare diseases

Oct 05, 2016

Amadeus Capital Partners, the global technology investor, has made an early-stage investment of £1.5 million in ideaSpace alumni Healx, a Cambridge based healthcare company that seeks new uses for existing drugs in the fight against rare diseases.

View all news